| Feasibility and therapeutic potential of 177Lu–fibroblast activation protein inhibitor–46 for patients with relapsed or refractory cancers: a preliminary study M Assadi, SJ Rekabpour, E Jafari, GA Divband, B Nikkholgh, H Amini, ... Clinical nuclear medicine 46 (11), e523-e530, 2021 | 101 | 2021 |
| Theranostic approach in breast cancer: a treasured tailor for future oncology N Jokar, I Velikyan, H Ahmadzadehfar, SJ Rekabpour, E Jafari, HH Ting, ... Clinical nuclear medicine 46 (8), e410-e420, 2021 | 65 | 2021 |
| Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units M Assadi, A Gholamrezanezhad, N Jokar, M Keshavarz, M Picchio, ... European Journal of Nuclear Medicine and Molecular Imaging, 1, 2020 | 36 | 2020 |
| Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer … M Assadi, R Manafi-Farid, E Jafari, A Keshavarz, GA Divband, MM Moradi, ... Frontiers in Oncology 12, 1066926, 2022 | 21 | 2022 |
| Comparison of 18F-NaF Imaging, 99mTc-MDP Scintigraphy, and 18F-FDG for Detecting Bone Metastases H Dadgar, N Norouzbeigi, N Jokar, J Zareizadeh, A Gholamrezanezhad, ... World Journal of Nuclear Medicine 21 (01), 001-008, 2022 | 20 | 2022 |
| Precision medicine approach in prostate cancer M Assadi, N Jokar, M Ghasemi, I Nabipour, A Gholamrezanezhad, ... Current pharmaceutical design 26 (31), 3783-3798, 2020 | 15 | 2020 |
| Theranostics in brain tumors H Shooli, R Nemati, H Ahmadzadehfar, M Aboian, E Jafari, N Jokar, ... PET clinics 16 (3), 397-418, 2021 | 14 | 2021 |
| Radioimmunotherapy (RIT) in brain tumors A Gholamrezanezhad, H Shooli, N Jokar, R Nemati, M Assadi Nuclear Medicine and Molecular Imaging 53 (6), 374-381, 2019 | 13 | 2019 |
| Bench-to-bedside theranostics in nuclear medicine N Jokar, M Assadi, A Yordanova, H Ahmadzadehfar Current Pharmaceutical Design 26 (31), 3804-3811, 2020 | 12 | 2020 |
| State-of-the-art modalities in cardio-oncology: Insight from a nuclear medicine approach N Jokar, A Amini, M Ravanbod, M Barekat, H Shooli, ... Nuclear Medicine Review 24 (2), 82-92, 2021 | 8 | 2021 |
| PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach H Dadgar, N Jokar, R Nemati, M Larvie, M Assadi Frontiers in Nuclear Medicine 3, 1103262, 2023 | 6 | 2023 |
| Multimodal assessment of regional gray matter integrity in early relapsing-remitting multiple sclerosis patients with normal cognition: a voxel-based structural and perfusion … H Shooli, R Nemati, N Chabi, M Larvie, N Jokar, H Dadgar, ... The British Journal of Radiology 94 (1127), 20210308, 2021 | 4 | 2021 |
| The online attention to certain nuclear medicine topics: An altmetrics study vs. a citation analysis S Seyyedhosseini, A Khosravi, M Assadi, N Jokar, RB Jahromi Iranian Journal of Nuclear Medicine 29 (2), 65, 2021 | 4 | 2021 |
| Theranostic approach in liver cancer: an emerging paradigm to optimize personalized medicine N Jokar, F Moradhaseli, H Ahmadzadehfar, E Jafari, S Nikeghbalian, ... Clinical and Translational Imaging 11 (1), 51-70, 2023 | 3 | 2023 |
| Coronavirus disease 2019 (COVID-19): a clinical guide A Gholamrezanezhad, MP Dube John Wiley & Sons, 2022 | 3 | 2022 |
| Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE in Advanced Neuroendocrine Tumors (NETs) in a Limited-Resource Environment M Kalantarhormozi, S Hassanzadeh, SJ Rekabpour, MR Ravanbod, ... World Journal of Nuclear Medicine 21 (03), 215-221, 2022 | 3 | 2022 |
| Estimating the risk of cancer incidence and radiation-induced cancer death of children patients undergoing digital radiology X-ray examinations N Jokar, B Mohsenzadeh, K Shamsi, R Aslani Journal of Radiation Research and Applied Sciences 16 (4), 100733, 2023 | 2 | 2023 |
| A path to new normal of nuclear medicine facilities: Considerations for reopening F Abbasi, A Gholamrezanezhad, N Jokar, M Assadi Asia Oceania Journal of Nuclear Medicine and Biology 9 (1), 80, 2021 | 2 | 2021 |
| Prognostic Factors in the Survival Rate of Patients with Differentiated Thyroid Cancer M Abbaszadeh, A Tangestani, N Jokar, M Ravanbod, M KalantarHormozi Iranian South Medical Journal 23 (3), 248-256, 2020 | 2 | 2020 |
| Advanced modalities of molecular imaging in precision medicine for musculoskeletal malignancies N Jokar, E Velez, H Shooli, H Dadgar, SA Sadathosseini, M Assadi, ... World journal of nuclear medicine 18 (04), 345-350, 2019 | 2 | 2019 |
Majid Assadi, MD,MSc(Adv.Onc.),FAS...Bushehr Medical Center HospitalAdresse e-mail validée de bpums.ac.ir